p.92 抽出テキスト

568. Zilberszac R, Heinze G, Binder T, Laufer G, Gabriel H, Rosenhek R. Long-term outcome of active surveillance in severe but asymptomatic primary mitral regurgitation. JACC Cardiovasc Imaging 2018;11:1213–21. https://doi.org/10.1016/j.jcmg.2018.05.014 569. Sengupta A, Yazdchi F, Alexis SL, Percy E, Premkumar A, Hirji S, et al. Reoperative mitral surgery versus transcatheter mitral valve replacement: a systematic review. J Am Heart Assoc 2021;10:e019854. https://doi.org/10.1161/JAHA.120.019854 570. Simonato M, Whisenant B, Ribeiro HB, Webb JG, Kornowski R, Guerrero M, et al. Transcatheter mitral valve replacement after surgical repair or replacement: comprehensive midterm evaluation of valve-in-valve and valve-in-ring implantation from the VIVID registry. Circulation 2021;143:104–16. https://doi.org/10.1161/ CIRCULATIONAHA.120.049088 571. Sugiura A, Kavsur R, Spieker M, Iliadis C, Goto T, Öztürk C, et al. Recurrent mitral regurgitation after MitraClip: predictive factors, morphology, and clinical implication. Circ Cardiovasc Interv 2022;15:e010895. https://doi.org/10.1161/CIRCINTERVENTIONS. 121.010895 572. Zaid S, Avvedimento M, Vitanova K, Akansel S, Bhadra OD, Ascione G, et al. Impact of mitral regurgitation etiology on mitral surgery after transcatheter edge-to-edge repair: from the CUTTING-EDGE registry. JACC Cardiovasc Interv 2023;16:1176–88. https:// doi.org/10.1016/j.jcin.2023.02.029 573. Bartkowiak J, Reineke D, Tomii D, Brugger N, Pilgrim T, Terbeck S, et al. Electrosurgical laceration and stabilization of MitraClip followed by valve implantation for iatrogenic mitral stenosis. JACC Cardiovasc Interv 2022;15:110–12. https://doi.org/10.1016/j.jcin. 2021.10.011 574. Lisko JC, Greenbaum AB, Guyton RA, Kamioka N, Grubb KJ, Gleason PT, et al. Electrosurgical detachment of MitraClips from the anterior mitral leaflet prior to transcatheter mitral valve implantation. JACC Cardiovasc Interv 2020;13:2361–70. https://doi.org/10.1016/j.jcin.2020.06.047 575. Huang AL, Dal-Bianco JP, Levine RA, Hung JW. Secondary mitral regurgitation: cardiac remodeling, diagnosis, and management. Struct Heart 2022;7:100129. https://doi.org/ 10.1016/j.shj.2022.100129 576. Bartko PE, Heitzinger G, Pavo N, Heitzinger M, Spinka G, Prausmüller S, et al. Burden, treatment use, and outcome of secondary mitral regurgitation across the spectrum of heart failure: observational cohort study. BMJ 2021;373:n1421. https://doi.org/10. 1136/bmj.n1421 577. Deferm S, Bertrand PB, Verbrugge FH, Verhaert D, Rega F, Thomas JD, et al. Atrial functional mitral regurgitation: JACC review topic of the week. J Am Coll Cardiol 2019;73:2465–76. https://doi.org/10.1016/j.jacc.2019.02.061 578. Mori M, Zogg CK, Amabile A, Fereydooni S, Agarwal R, Weininger G, et al. Impact of secondary mitral regurgitation on survival in atrial and ventricular dysfunction. PLoS One 2022;17:e0277385. https://doi.org/10.1371/journal.pone.0277385 579. Moonen A, Ng MKC, Playford D, Strange G, Scalia GM, Celermajer DS. Atrial functional mitral regurgitation: prevalence, characteristics and outcomes from the National Echo Database of Australia. Open Heart 2023;10:e002180. https://doi.org/10.1136/ openhrt-2022-002180 580. Okamoto C, Okada A, Nishimura K, Moriuchi K, Amano M, Takahama H, et al. Prognostic comparison of atrial and ventricular functional mitral regurgitation. Open Heart 2021;8:e001574. https://doi.org/10.1136/openhrt-2021-001574 581. Farhan S, Silbiger JJ, Halperin JL, Zhang L, Dukkipati SR, Vogel B, et al. Pathophysiology, echocardiographic diagnosis, and treatment of atrial functional mitral regurgitation: JACC state-of-the-art review. J Am Coll Cardiol 2022;80:2314–30. https://doi.org/10. 1016/j.jacc.2022.09.046 582. Naser JA, Michelena HI, Lin G, Scott CG, Lee E, Kennedy AM, et al. Incidence, risk factors, and outcomes of atrial functional mitral regurgitation in patients with atrial fibrillation or sinus rhythm. Eur Heart J Cardiovasc Imaging 2023;24:1450–7. https://doi.org/ 10.1093/ehjci/jead199 583. Stone GW, Lindenfeld J, Abraham WT, Kar S, Lim DS, Mishell JM, et al. Transcatheter mitral-valve repair in patients with heart failure. N Engl J Med 2018;379:2307–18. https://doi.org/10.1056/NEJMoa1806640 584. Stone GW, Abraham WT, Lindenfeld J, Kar S, Grayburn PA, Lim DS, et al. Five-year follow-up after transcatheter repair of secondary mitral regurgitation. N Engl J Med 2023;388:2037–48. https://doi.org/10.1056/NEJMoa2300213 585. Cavalcante JL, Kusunose K, Obuchowski NA, Jellis C, Griffin BP, Flamm SD, et al. Prognostic impact of ischemic mitral regurgitation severity and myocardial infarct quantification by cardiovascular magnetic resonance. JACC Cardiovasc Imaging 2020; 13:1489–501. https://doi.org/10.1016/j.jcmg.2019.11.008 586. Kim K, Kitai T, Kaji S, Pak M, Toyota T, Sasaki Y, et al. Outcomes and predictors of cardiac events in medically treated patients with atrial functional mitral regurgitation. Int J Cardiol 2020;316:195–202. https://doi.org/10.1016/j.ijcard.2020.06.042 587. Mesi O, Gad MM, Crane AD, Ramchand J, Puri R, Layoun H, et al. Severe atrial functional mitral regurgitation: clinical and echocardiographic characteristics, management and outcomes. JACC Cardiovasc Imaging 2021;14:797–808. https://doi.org/10.1016/j. jcmg.2021.02.008 588. Doldi P, Stolz L, Orban M, Karam N, Praz F, Kalbacher D, et al. Transcatheter mitral valve repair in patients with atrial functional mitral regurgitation. JACC Cardiovasc Imaging 2022;15:1843–51. https://doi.org/10.1016/j.jcmg.2022.05.009 589. Masiero G, Montonati C, Rubbio AP, Adamo M, Grasso C, Denti P, et al. Impact of transcatheter edge-to-edge mitral valve repair on atrial functional mitral regurgitation from the GIOTTO registry. Am J Cardiol 2024;211:219–27. https://doi.org/10.1016/j. amjcard.2023.11.007 590. Yoon SH, Makar M, Kar S, Chakravarty T, Oakley L, Sekhon N, et al. Outcomes after transcatheter edge-to-edge mitral valve repair according to mitral regurgitation etiology and cardiac remodeling. JACC Cardiovasc Interv 2022;15:1711–22. https://doi. org/10.1016/j.jcin.2022.07.004 591. Chen QF, Zhou X, Katsouras CS, Ni C, Zhu H, Liu C, et al. Atrial and ventricular functional mitral regurgitation: prevalence, characteristics, outcomes, and disease progression. Eur Heart J Cardiovasc Imaging 2024;26:545–56. https://doi.org/10.1093/ehjci/ jeae309 592. von Stein P, von Stein J, Hohmann C, Wienemann H, Guthoff H, Körber MI, et al. Atrial functional mitral regurgitation subtypes undergoing transcatheter edge-to-edge repair: suboptimal outcomes in atriogenic hamstringing. JACC Cardiovasc Imaging 2025;18: 16–29. https://doi.org/10.1016/j.jcmg.2024.06.019 593. Rosano GMC, Moura B, Metra M, Böhm M, Bauersachs J, Ben Gal T, et al. Patient profiling in heart failure for tailoring medical therapy. A consensus document of the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail 2021;23: 872–81. https://doi.org/10.1002/ejhf.2206 594. Mebazaa A, Davison B, Chioncel O, Cohen-Solal A, Diaz R, Filippatos G, et al. Safety, tolerability and efficacy of up-titration of guideline-directed medical therapies for acute heart failure (STRONG-HF): a multinational, open-label, randomised, trial. Lancet 2022;400:1938–52. https://doi.org/10.1016/s0140-6736(22)02076-1 595. Spinka G, Bartko PE, Heitzinger G, Prausmuller S, Winter MP, Arfsten H, et al. Guideline directed medical therapy and reduction of secondary mitral regurgitation. Eur Heart J Cardiovasc Imaging 2022;23:755–64. https://doi.org/10.1093/ehjci/jeac068 596. Pagnesi M, Adamo M, Sama IE, Anker SD, Cleland JG, Dickstein K, et al. Clinical impact of changes in mitral regurgitation severity after medical therapy optimization in heart failure. Clin Res Cardiol 2022;111:912–23. https://doi.org/10.1007/s00392- 022-01991-7 597. Di Biase L, Auricchio A, Mohanty P, Bai R, Kautzner J, Pieragnoli P, et al. Impact of cardiac resynchronization therapy on the severity of mitral regurgitation. Europace 2011; 13:829–38. https://doi.org/10.1093/europace/eur047 598. Glikson M, Nielsen JC, Kronborg MB, Michowitz Y, Auricchio A, Barbash IM, et al. 2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy. Eur Heart J 2021;42:3427–520. https://doi.org/10.1093/eurheartj/ehab364 599. Michalski B, Stankovic I, Pagourelias E, Ciarka A, Aarones M, Winter S, et al. Relationship of mechanical dyssynchrony and LV remodeling with improvement of mitral regurgitation after CRT. JACC Cardiovasc Imaging 2022;15:212–20. https://doi.org/ 10.1016/j.jcmg.2021.08.010 600. Ypenburg C, Lancellotti P, Tops LF, Bleeker GB, Holman ER, Pierard LA, et al. Acute effects of initiation and withdrawal of cardiac resynchronization therapy on papillary muscle dyssynchrony and mitral regurgitation. J Am Coll Cardiol 2007;50:2071–7. https://doi.org/10.1016/j.jacc.2007.08.019 601. Obadia JF, Messika-Zeitoun D, Leurent G, Iung B, Bonnet G, Piriou N, et al. Percutaneous repair or medical treatment for secondary mitral regurgitation. N Engl J Med 2018;379:2297–306. https://doi.org/10.1056/NEJMoa1805374 602. Iung B, Armoiry X, Vahanian A, Boutitie F, Mewton N, Trochu JN, et al. Percutaneous repair or medical treatment for secondary mitral regurgitation: outcomes at 2 years. Eur J Heart Fail 2019;21:1619–27. https://doi.org/10.1002/EJHF.1616 603. Grayburn PA, Sannino A, Packer M. Proportionate and disproportionate functional mitral regurgitation: a new conceptual framework that reconciles the results of the MITRA-FR and COAPT trials. JACC Cardiovasc Imaging 2019;12:353–62. https://doi. org/10.1016/j.jcmg.2018.11.006 604. Senni M, Adamo M, Metra M, Alfieri O, Vahanian A. Treatment of functional mitral regurgitation in chronic heart failure: can we get a ‘proof of concept’ from the MITRA-FR and COAPT trials? Eur J Heart Fail 2019;21:852–61. https://doi.org/10.1002/EJHF.1491 605. Pibarot P, Delgado V, Bax JJ. MITRA-FR vs. COAPT: lessons from two trials with diametrically opposed results. Eur Heart J Cardiovasc Imaging 2019;20:620–24. https://doi. org/10.1093/ehjci/jez073 606. Anker SD, Friede T, von Bardeleben RS, Butler J, Khan MS, Diek M, et al. Transcatheter valve repair in heart failure with moderate to severe mitral regurgitation. N Engl J Med 2024;391:1799–809. https://doi.org/10.1056/NEJMoa2314328 607. Anker MS, Porthun J, Bonnet G, Schulze PC, Rassaf T, Landmesser U. Percutaneous transcatheter edge-to-edge repair for functional mitral regurgitation in heart failure: a meta-analysis of 3 randomized controlled trials. J Am Coll Cardiol 2024;84: 2364–68. https://doi.org/10.1016/j.jacc.2024.08.026 608. Koell B, Orban M, Weimann J, Kassar M, Karam N, Neuss M, et al. Outcomes stratified by adapted inclusion criteria after mitral edge-to-edge repair. J Am Coll Cardiol 2021;78: 2408–21. https://doi.org/10.1016/j.jacc.2021.10.011 609. Scotti A, Latib A, Rubbio AP, Testa L, Adamo M, Denti P, et al. Derivation and validation of a clinical risk score for COAPT-ineligible patients who underwent transcatheter edge-to-edge repair. Am J Cardiol 2023;186:100–8. https://doi.org/10.1016/j. amjcard.2022.10.024 Downloaded from academic.oup.com/eurheartj/article/46/44/4635/8234488 by guest on 07 October 2026